ResMed | RMD - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Ansell USD 20.6M 300K 2025-12
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.37M 42K 2025-12
Baxter International USD 58M 14M 2025-09
Cochlear AUD 6.3M 3.65M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
CSL USD 215M 111M 2025-12
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Fisher Paykel Healthcare NZD 5.5M 700K 2025-12
Globus Medical USD 5.44B 5.44B 2026-03
Haemonetics USD 7.4M 190K 2025-12
Idexx Laboratories USD 7.74M 2.34M 2026-03
Inogen 1.03M 384K 2025-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
Intuitive Surgical USD 20.11B 58.39B 2026-03
Masimo USD 6.1M 1.4M 2026-03
Medtronic USD 181M 0 2025-12
Philips EUR 83M 26M 2026-03
Ramsay Health Care AUD 300.6M 15.5M 2025-12
ResMed USD 8.79M 14.55M 2025-09
Sigma Healthcare AUD 7.97M 365K 2024-01
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Steris USD 14.9M 0 2025-12
Teleflex USD 25.72M 2.43M 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03